## Labetalol: A Unique Combined Alpha-Beta Blocker **Key Point:** Labetalol is a combined alpha and beta blocker with a 7:1 ratio of beta to alpha blocking activity. It also possesses membrane-stabilizing (quinidine-like) properties, making it unique among beta blockers. ### Pharmacological Properties of Labetalol 1. **Beta-blocking activity** — non-selective (blocks both β₁ and β₂ receptors) 2. **Alpha-blocking activity** — blocks α₁ receptors (7:1 beta:alpha ratio) 3. **Membrane stabilization** — quinidine-like effect on cardiac action potential 4. **Vasodilation** — alpha blockade causes peripheral vasodilation ### Clinical Features | Feature | Benefit | | --- | --- | | Combined α + β blockade | Reduces BP without reflex tachycardia | | Non-selective beta blockade | Effective in hypertension and arrhythmias | | Membrane stabilization | Antiarrhythmic properties | | Vasodilation | Preserves renal and cerebral blood flow | ### Clinical Uses - **Hypertensive emergencies** — rapid onset, IV formulation available - **Hypertension in pregnancy** — safe, no fetal effects - **Hypertension with concurrent arrhythmias** — dual benefit - **Patients requiring both alpha and beta blockade** — single agent simplifies therapy **High-Yield:** Labetalol is the ONLY beta blocker with alpha-blocking properties and membrane stabilization. It is the preferred agent for hypertensive emergencies in pregnancy and is frequently tested in NEET PG. **Mnemonic:** **LABE** = **L**abetalol has **A**lpha and **B**eta blockade plus membrane stabilization (E = extra property). **Clinical Pearl:** Labetalol does not cause reflex tachycardia despite lowering blood pressure because its alpha blockade prevents sympathetic activation — a major advantage over pure beta blockers in hypertensive crises.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.